ATP6V0A4

Item Information
Catalog #
Size
Price
Description

This gene encodes a component of vacuolar ATPase (V-ATPase), a multisubunit enzyme that mediates acidification of intracellular compartments of eukaryotic cells. V-ATPase dependent acidification is necessary for such intracellular processes as protein sorting, zymogen activation, receptor-mediated endocytosis, and synaptic vesicle proton gradient generation. V-ATPase is composed of a cytosolic V1 domain and a transmembrane V0 domain. The V1 domain consists of three A and three B subunits, two G subunits plus the C, D, E, F, and H subunits. The V1 domain contains the ATP catalytic site. The V0 domain consists of five different subunits: a, c, c', c'', and d. This gene is one of four genes in man and mouse that encode different isoforms of the a subunit. Alternatively spliced transcript variants encoding the same protein have been described. Mutations in this gene are associated with renal tubular acidosis associated with preserved hearing.

Product Overview
Entrez GenelD
50617
Aliases
A4; STV1; VPH1; VPP2; DRTA3; RTA1C; RTADR; ATP6N2; RDRTA2; ATP6N1B
Clone#
9C9H9
Host / Isotype
Mouse / Mouse IgG1
Species Reactivity
Human
Immunogen
Purified recombinant fragment of human ATP6V0A4 (AA: 228-390) expressed in E. Coli.
Formulation
Purified antibody in PBS with 0.05% sodium azide
Storage
4℃; -20℃ for long term storage
Product Applications
WB (Western Blot)
1/500 - 1/2000
IHC_P(Immunohistochemistry)
1/200 - 1/1000
FCM (Flow Cytometry)
1/200 - 1/400
ELISA
1/10000
References
1.Clin Nephrol. 2014 Feb;81(2):142-5.
2.J Genet. 2014 Dec;93(3):859-63.
Product Image
Elisa
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)
Western Blot
Figure 2:Western blot analysis using ATP6V0A4 mAb against human ATP6V0A4 (AA: 228-390) recombinant protein. (Expected MW is 44.5 kDa)
Figure 2:Western blot analysis using ATP6V0A4 mAb against human ATP6V0A4 (AA: 228-390) recombinant protein. (Expected MW is 44.5 kDa)
Western Blot
Figure 3:Western blot analysis using ATP6V0A4 mAb against HEK293-6e (1) and ATP6V0A4 (AA: 228-390)-hIgGFc transfected HEK293-6e (2) cell lysate.
Figure 3:Western blot analysis using ATP6V0A4 mAb against HEK293-6e (1) and ATP6V0A4 (AA: 228-390)-hIgGFc transfected HEK293-6e (2) cell lysate.
Immunofluorescence analysis
Figure 4:Flow cytometric analysis of Hela cells using ATP6V0A4 mouse mAb (green) and negative control (red).
Figure 4:Flow cytometric analysis of Hela cells using ATP6V0A4 mouse mAb (green) and negative control (red).
Immunohistochemical analysis
Figure 5:Immunohistochemical analysis of paraffin-embedded breast cancer tissues using ATP6V0A4 mouse mAb with DAB staining.
Figure 5:Immunohistochemical analysis of paraffin-embedded breast cancer tissues using ATP6V0A4 mouse mAb with DAB staining.
Immunohistochemical analysis
Figure 6:Immunohistochemical analysis of paraffin-embedded human kidney tissues using ATP6V0A4 mouse mAb with DAB staining.
Figure 6:Immunohistochemical analysis of paraffin-embedded human kidney tissues using ATP6V0A4 mouse mAb with DAB staining.
For Research Use Only. Not for use in diagnostic procedures.